Skip to Main Content

Paper Details

Are higher follicle-stimulating hormone levels before androgen deprivation therapy for prostate cancer associated with oncological and cardiac outcomes and overall survival?-a population-level analysis.
Transl Androl Urol
1
2023
Author NameAffiliation
Stephen J FreedlandSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Stephen J Freedland
Stephen J FreedlandCenter for Integrated Research in Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
  • 1 - 3

Datasets

Release 1.2